These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6170735)

  • 1. Antibiotics and antivirals do not modify experimentally-induced Creutzfeldt-Jakob disease in mice.
    Tateishi J
    J Neurol Neurosurg Psychiatry; 1981 Aug; 44(8):723-4. PubMed ID: 6170735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual clinical course in a case of Creutzfeldt-Jakob disease.
    Villa G; Caltagirone C; Macchi G
    Ital J Neurol Sci; 1982 Jul; 3(2):155-8. PubMed ID: 6181011
    [No Abstract]   [Full Text] [Related]  

  • 3. Antivirals with clinical potential.
    Luby JP
    Adv Intern Med; 1979; 24():229-54. PubMed ID: 85407
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic control of scrapie and Creutzfeldt-Jakob disease in mice.
    Kingsbury DT; Kasper KC; Stites DP; Watson JD; Hogan RN; Prusiner SB
    J Immunol; 1983 Jul; 131(1):491-6. PubMed ID: 6408182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of amantadine on arousal and EEG patterns in Creutzfeldt-Jakob disease.
    Terzano MG; Montanari E; Calzetti S; Mancia D; Lechi A
    Arch Neurol; 1983 Sep; 40(9):555-9. PubMed ID: 6351817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease treated with amantadine.
    Sanders WL
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):960-1. PubMed ID: 390098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine in the treatment of Creutzfeldt-Jakob disease.
    Braham J
    Arch Neurol; 1984 Jun; 41(6):585-6. PubMed ID: 6372758
    [No Abstract]   [Full Text] [Related]  

  • 8. Creutzfeldt-Jakob disease treated with amantidine. A report of two cases.
    Sanders WL; Dunn TL
    J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):581-4. PubMed ID: 4581346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creutzfeldt-Jakob disease with focal onset unsuccessfully treated with amantadine.
    Ratcliffe J; Rittman A; Wolf S; Verity MA
    Bull Los Angeles Neurol Soc; 1975 Jan; 40(1):18-20. PubMed ID: 1097004
    [No Abstract]   [Full Text] [Related]  

  • 10. [Amantadine in Creutzfeldt-Jakob disease. Review of the literature and case contribution].
    Neri G; FigĂ -Talamanca L; Di Battista GC; Lo Russo F
    Riv Neurobiol; 1984; 30(1):47-56. PubMed ID: 6399949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiviral therapy today].
    Tovo PA
    Minerva Med; 1980 Dec; 71(49):3633-7. PubMed ID: 6161324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral drugs in Jakob-Creutzfeldt disease.
    Herishanu Y
    J Am Geriatr Soc; 1973 May; 21(5):229-31. PubMed ID: 4575371
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental transmission of Creutzfeldt-Jakob disease.
    Tateishi J; Koga M; Mori R
    Acta Pathol Jpn; 1981 Nov; 31(6):943-51. PubMed ID: 7032196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine in Jakob-Creutzfeldt disease.
    Norris FH
    Br Med J; 1972 May; 2(5809):349. PubMed ID: 4553821
    [No Abstract]   [Full Text] [Related]  

  • 15. Jakob-Creutzfeldt disease: treatment by amantadine.
    Braham J
    Br Med J; 1971 Oct; 4(5781):212-3. PubMed ID: 4940159
    [No Abstract]   [Full Text] [Related]  

  • 16. Host genetic control of incubation periods of Creutzfeldt-Jakob disease in mice.
    Mohri S; Tateishi J
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1391-400. PubMed ID: 2659733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic prospects for subacute transmissible spongiform encephalopathies].
    Seman M; Adjou KT
    Rev Prat; 1999 May; 49(9):971-5. PubMed ID: 11865463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral chemotherapy.
    Med Lett Drugs Ther; 1971 Sep; 13(19):77-8. PubMed ID: 4328547
    [No Abstract]   [Full Text] [Related]  

  • 19. Amyloid plaques in the brains of mice with Creutzfeldt-Jakob disease.
    Tateishi J; Nagara H; Hikita K; Sato Y
    Ann Neurol; 1984 Mar; 15(3):278-80. PubMed ID: 6372648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral treatment of subacute sclerosing panencephalitis].
    Sobczyk W; Kulczycki J
    Neurol Neurochir Pol; 1981; 15(2):143-8. PubMed ID: 6167886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.